Abbott’s MitraClip implant just got a new sibling. The FDA has approved the company’s Tendyne system, as a minimally invasive heart replacement for patients with mitral valve disease that would ...
(Reuters) - Staff reviewers for the Food and Drug Administration did not recommend the approval of Abbott Laboratories' implantable heart device MitraClip, citing a lack of "valid scientific evidence" ...
On February 15, FDA announced that Abbott Vascular has received nine reports of its MitraClip delivery system failing to detach from the Clip, which resulted in the death of one patient and open-heart ...
In 2016, medical device giant Abbott issued a recall for its MitraClip cardiac device — “a Class I recall, the most serious type,” the FDA said. “Use of this device may cause serious injuries or death ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results